Tumour-associated glycan modifications o
✍
Satwinder Kaur Singh; Ingeborg Streng-Ouwehand; Manja Litjens; Hakan Kalay; Eiri
📂
Article
📅
2011
🏛
John Wiley and Sons
🌐
French
⚖ 698 KB
## Abstract We recently showed that MGL2 specifically binds tumour‐associated glycan __N__‐acetylgalactosamine (GalNAc). We here demonstrate that modification of an antigen with tumour‐associated glycan GalNAc, targets antigen specifically to the MGL2 on bone marrow derived (BM)‐DCs and splenic DCs